Therapeutic angiogenesis using adipose-derived regenerative cells
Project/Area Number |
21590951
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Circulatory organs internal medicine
|
Research Institution | Nagoya University |
Principal Investigator |
SHINTANI Satoshi 名古屋大学, 大学院・医学系研究科, 講師 (20309777)
|
Co-Investigator(Kenkyū-buntansha) |
MUROHARA Toyoaki 名古屋大学, 大学院・医学系研究科, 教授 (90299503)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 血管新生療法 / 脂肪由来間葉系前駆細胞 / リンパ管新生 / マクロファージ / 脂肪組織由来間葉系前駆細胞 / セリューションシステム / ヒト幹細胞臨床研究 / 血管新生 / 組織浮腫 |
Research Abstract |
It has been known that adipose-derived regenerative cells(ADRCs) secrete multiple angiogenic growth factors. We reported that ADRCs implantation improve severe ischemia and seems to be a useful strategy of therapeutic angiogenesis. Next, we focused on VEGF-C that ADRCs released. ADRCs therapy increased lymphatic capillary density and significantly reduced tissue edema. We consider that BM derived M2 macrophages plays an important role in postnatal lymphangiogenesis.
|
Report
(4 results)
Research Products
(43 results)